"text","instanceType","description","id","label","name","uuid:ID"
"To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective","Main objective","Objective_1","","OBJ1","e119a521-c87d-4e62-88db-521404440dda"
"To document the safety profile of the xanomeline TTS.","Objective","Safety","Objective_2","","OBJ2","1e21f250-d683-4d8a-9b75-ef6de5b8c817"
"To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective","Behaviour","Objective_3","","OBJ3","9755a377-88ca-42a0-aa1c-275203980be9"
